Literature DB >> 11331844

Trends in the incidence of venous stasis syndrome and venous ulcer: a 25-year population-based study.

J A Heit1, T W Rooke, M D Silverstein, D N Mohr, C M Lohse, T M Petterson, W M O'Fallon, L J Melton.   

Abstract

BACKGROUND: The incidence rates of venous stasis syndrome and venous ulcer are uncertain, and trends in incidence are unknown.
METHODS: We performed a retrospective review of the complete (inpatient and outpatient) medical records of a community population (Olmsted County, Minnesota) to estimate the incidence of venous stasis syndrome and venous ulcer during the 25-year period, 1966 to 1990, and to describe trends in incidence.
RESULTS: A total of 1131 patients received a first lifetime diagnosis of venous stasis syndrome. A total of 263 patients received a first lifetime diagnosis of venous ulcer. The overall incidence of venous stasis syndrome and venous ulcer were 76.1 and 18.0 per 100,000 person-years, respectively. The incidence of both was higher in women than in men (83.7 vs 67.4 per 100,000 person-years for venous stasis syndrome; 20.4 vs 14.6 per 100,000 for venous ulcer) and increased with age for both sexes. There was no clear trend in the incidence of venous stasis syndrome over the 25-year period. Compared with 1966 to 1970, the incidence of venous ulcer decreased in 1971 to 1980, but was unchanged after 1981. Among 945 patients with venous stasis only, 60 subsequently had a venous ulcer. The average (+/- SD) time from venous stasis diagnosis to development of a venous ulcer was 5.0 (+/- 5.0) years.
CONCLUSION: Venous stasis syndrome and venous ulcer are common, especially in the elderly population. The incidence of venous stasis syndrome has not changed since 1966, and venous ulcer incidence is unchanged since 1981. More accurate identification of patients at risk for venous stasis syndrome and venous ulcer and more effective prevention are needed.

Entities:  

Mesh:

Year:  2001        PMID: 11331844     DOI: 10.1067/mva.2001.113308

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  30 in total

1.  Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.

Authors:  Laura McCullagh; Cathal Walsh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

2.  Impact of venous thromboembolism, venous stasis syndrome, venous outflow obstruction and venous valvular incompetence on quality of life and activities of daily living: a nested case-control study.

Authors:  Aneel A Ashrani; Marc D Silverstein; Thom W Rooke; Brian D Lahr; Tanya M Petterson; Kent R Bailey; L Joseph Melton; John A Heit
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

3.  [Epidemiology of chronic venous diseases]].

Authors:  F Pannier-Fischer; E Rabe
Journal:  Hautarzt       Date:  2003-11       Impact factor: 0.751

Review 4.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

Review 5.  The epidemiology of venous thromboembolism in the community.

Authors:  John A Heit
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

6.  Stratifying the risk of venous thromboembolism in otolaryngology.

Authors:  Andrew G Shuman; Hsou Mei Hu; Christopher J Pannucci; Christopher R Jackson; Carol R Bradford; Vinita Bahl
Journal:  Otolaryngol Head Neck Surg       Date:  2012-01-18       Impact factor: 3.497

Review 7.  [Epidemiology of chronic venous diseases].

Authors:  Eberhard Rabe; Gabriele Berboth; Felizitas Pannier
Journal:  Wien Med Wochenschr       Date:  2016-06-08

8.  Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China.

Authors:  Xiaoyu Yan; Xiaohua Gu; Lei Zhou; Houweng Lin; Bin Wu
Journal:  Clin Drug Investig       Date:  2016-12       Impact factor: 2.859

Review 9.  The epidemiology of skin and skin-related diseases: a review of population-based studies performed by using the Rochester Epidemiology Project.

Authors:  Louise K Andersen; Mark D P Davis
Journal:  Mayo Clin Proc       Date:  2013-12       Impact factor: 7.616

Review 10.  Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide.

Authors:  Laurel L Wessman; Louise K Andersen; Mark D P Davis
Journal:  Int J Dermatol       Date:  2018-01-29       Impact factor: 2.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.